WCN26-6607 AGREEMENT BETWEEN LABORATORY AND POINT-OF-CARE CREATININE–BASED RISK ASSESSMENT FOR POST-CONTRAST ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING ANGIOGRAPHY

Abduzhappar Gaipov, Alimzhan Muxunov, Doskhan Kozhakhmet, Symbat Bayakhmetova, Meruyert Madikenova, Anara Abbay, Zhanat Kuanshaliyeva, Yerlan Zhumagulov, Marat Alikhanov

2026

Full text Open access: Gold Metadata (CSL-JSON)

DOI 10.1016/j.ekir.2026.104003

Data confidence 70 medium

How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Rapid identification of patients at risk of contrast-induced acute kidney injury (AKI) is essential in acute settings such as myocardial infarction (MI) and stroke. Point-of-care (POC) creatinine testing offers immediate kidney function results, but its reliability compared with standard laboratory measurements remains uncertain. This study evaluated the agreement between laboratory and POC creatinine–based risk stratification and their association with subsequent AKI after contrast angiography.